Michael Cannon-Brookes Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock

Atlassian Corporation PLC (NASDAQ:TEAM) CEO Michael Cannon-Brookes sold 7,665 shares of Atlassian stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $162.66, for a total transaction of $1,246,788.90. Following the completion of the transaction, the chief executive officer directly owned 283,605 shares of the company’s stock, valued at $46,131,189.30. This trade represents a 2.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Michael Cannon-Brookes also recently made the following trade(s):

• On Monday, November 3rd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $172.78, for a total transaction of $1,324,358.70.
• On Friday, October 31st, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $167.61, for a total transaction of $1,284,730.65.
• On Wednesday, October 29th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $160.40, for a total value of $1,229,466.00.
• On Monday, October 27th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $165.03, for a total value of $1,264,954.95.
• On Friday, October 24th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $164.50, for a total value of $1,260,892.50.
• On Wednesday, October 22nd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $169.16, for a total value of $1,296,611.40.
• On Friday, October 17th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.21, for a total value of $1,159,024.65.
• On Monday, October 20th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $157.28, for a total value of $1,205,551.20.
• On Wednesday, October 15th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.83, for a total value of $1,163,776.95.
• On Monday, October 13th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.81, for a total transaction of $1,132,963.65.

Atlassian Stock Up 1.1%

Atlassian stock opened at $157.83 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.22 and a current ratio of 1.26. Atlassian Corporation PLC has a one year low of $144.32 and a one year high of $326.00. The company has a 50-day simple moving average of $163.23 and a 200-day simple moving average of $186.66. The firm has a market capitalization of $41.40 billion, a P/E ratio of -222.29, a P/E/G ratio of 37.03 and a beta of 0.95.

Atlassian (NASDAQ:TEAM) last issued its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.21. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.40 billion. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.11%. Atlassian’s quarterly revenue was up 20.6% compared to the same quarter last year. During the same period last year, the firm posted $0.77 EPS. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts expect that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.

Institutional Trading of Atlassian

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Capco Asset Management LLC bought a new position in Atlassian during the second quarter valued at about $25,000. Physician Wealth Advisors Inc. raised its position in Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock worth $26,000 after acquiring an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp lifted its holdings in Atlassian by 19,900.0% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after acquiring an additional 199 shares during the last quarter. Smithfield Trust Co lifted its holdings in Atlassian by 90.7% in the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after acquiring an additional 78 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in shares of Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after purchasing an additional 161 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on TEAM shares. Guggenheim started coverage on Atlassian in a research report on Thursday, September 11th. They set a “buy” rating and a $225.00 price objective for the company. Oppenheimer lowered their target price on Atlassian from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Monday, July 21st. Sanford C. Bernstein reduced their price target on Atlassian from $296.00 to $290.00 and set an “outperform” rating for the company in a research report on Friday, October 31st. BMO Capital Markets increased their price target on Atlassian from $190.00 to $195.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $260.00 price target on shares of Atlassian in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $239.44.

About Atlassian

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.